HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of glycosaminoglycans stored in mucopolysaccharidosis III A: evidence for a generally occuring degradation of heparan sulfate by endoglycosidases.

Abstract
The characterization of intracellularly stored glycosaminoglycans from organs of a patient suffering from mucopolysaccharidosis III A (Sanfilippo A disease) is described. Both heparan sulfate and galactosamine-containing glycosaminoglycans (chondroitin sulfate, dermatan sulfate) are accumulated in the liver, whereas in the other organs (spleen, kidney, heart, cerebrum, cerebellum) heparan sulfate is almost the only glycosaminoglycan stored. It is shown by [3H]NaBH4 reduction and subsequent identification of the 3H-labelled sugar alcohols that heparan sulfate is degraded in all organs by at least two endoglycosidases, an endoglucuronidase and an endoglucosaminidase, to fragments of low molecular weight (Mr approximately 2 000-6 600).
AuthorsA Kindler, U Klein, K von Figura
JournalHoppe-Seyler's Zeitschrift fur physiologische Chemie (Hoppe Seylers Z Physiol Chem) Vol. 358 Issue 11 Pg. 1431-8 (Nov 1977) ISSN: 0018-4888 [Print] Germany
PMID411726 (Publication Type: Journal Article)
Chemical References
  • Carbohydrates
  • Glycosaminoglycans
  • Heparitin Sulfate
  • Glycoside Hydrolases
Topics
  • Carbohydrates (analysis)
  • Glycosaminoglycans (metabolism)
  • Glycoside Hydrolases
  • Heparitin Sulfate (metabolism)
  • Humans
  • Mucopolysaccharidoses (metabolism)
  • Mucopolysaccharidosis III (metabolism)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: